Combinatorial Latency Reactivation for HIV-1 Subtypes and Variants
J. Virol. Burnett et al. 84: 5958

Supplemental material

Files in this Data Supplement:

  • Supplemental file 1 - Fig. S1 (Cell viability after perturbation with antilatency drugs.)
    Fig. S2 (Analysis of Sp1 and κB polymorphisms in subtype B isolates from the LANL HIV-1 genome database.)
    Fig. S3 (GFP histograms of LGIT PheB clones with reactivation.)
    Fig. S4 (Single and combinatorial treatment with DNA methylase inhibitor 5-azadeoxycytidine.)
    Fig. S5 (Reactivation of LGIT Off-sorts harboring mutations in Sp1 or κB elements.)
    Fig. S6 (Sequence alignments of U3 regions for global subtypes and circulating recombinant forms.)
    Fig. S7 (GFP expression before and after T cell activation of primary cells.)
    Fig. S8 (Latency reactivation of LG clones with the subtype B LTR.)
    Table S1 (Primer sequences for QPCR.)
    Table S2 (Isolation and origin of HIV-1 subtype variants.)
    Table S3 (Summary of HIV-1 latency models.)
    PDF file, 3.5MB.